Es wurden 16 Aussendungen gefunden
  • Eli Lilly and Company
Eight out of 10 People Diagnosed With Heart Disease Consider Their Diagnosis a 'Wake-Up Call'

Barcelona, Spain (ots/PRNewswire) -

  • 31.08.2009, 16:37:04
  • /
  • OTE0012
  • Eli Lilly and Company
World Heart Federation, Daiichi Sankyo and Lilly Partner to Improve Cardiovascular Health

Orlando, Florida (ots/PRNewswire) -

  • 31.03.2009, 06:07:36
  • /
  • OTE0002
  • Eli Lilly and Company
New Data Show Duloxetine Maintained Pain Reduction for More Than Six Months in Patients With Diabetic Peripheral Neuropathic Pain

Indianapolis (ots/PRNewswire) -

  • 19.08.2008, 16:20:35
  • /
  • OTE0012
  • Eli Lilly and Company
Global 'Inspired by Diabetes' Creative Expression Competition Deadline Extended Until March 31, 2008

Indianapolis (ots/PRNewswire) -

  • 05.02.2008, 22:59:08
  • /
  • OTE0011
  • Eli Lilly and Company
Investigational Once-Weekly Exenatide Demonstrated Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study

San Diego, and Indianapolis, and Cambridge, Massachusetts (ots/PRNewswire) -

  • 31.10.2007, 14:15:37
  • /
  • OTE0010
  • Eli Lilly and Company
BYETTA(R) Study Showed Sustained Blood Glucose Control Over Three Years in People with Type 2 Diabetes

Chicago (ots/PRNewswire) -

  • 25.06.2007, 22:20:38
  • /
  • OTE0011
  • Eli Lilly and Company
BYETTA(R) Study Showed Comparable Blood Glucose Control to Insulin

Chicago (ots/PRNewswire) -

  • 24.06.2007, 22:50:09
  • /
  • OTE0002
  • Eli Lilly and Company
BYETTA(R) Treatment for Three and a Half Years Associated with Sustained Improvements in Blood Glucose Control in People with Type 2 Diabetes

Chicago (ots/PRNewswire) -

  • 23.06.2007, 17:06:06
  • /
  • OTE0002
  • Eli Lilly and Company
Lilly and International Diabetes Federation Announce Launch of 'Inspired by Diabetes' Creative Expression Competition

Indianapolis and Brussels, Belgium (ots/PRNewswire) -

  • 21.06.2007, 16:58:36
  • /
  • OTE0006
  • Eli Lilly and Company
Lilly kündigt weitere Investition in Höhe von 50 Mio.US$ in weltweite Partnerschaft zur Bekämpfung von Tuberkulose an

New York (ots/PRNewswire) -

  • 22.03.2007, 05:05:35
  • /
  • OTS0002 OTW0002